SONALASENSE, INC.
Oakland, CA · Founded 2019 · CIK 0001825955 · Medtech · Private
MRI-guided focused ultrasound device combined with 5-aminolevulinic acid drug for sonodynamic therapy of glioblastoma
sonalasense.com →- Grants
- $4.2M
- 5 awards
- Sector median: 1
- Raised
- $35M
- 4 Form D · Nov 2023
- 35 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 0 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $999,980 | |
| Private capital raised | Form D · SEC | $3,933,400 | |
| Private capital raised | Form D · SEC | $20,093,202 | |
| Federal grant | Department of Health and Human Services · Phase II · Evaluation of the safety and efficacy of non-invasive sonodynamic therapy for diffuse intrinsic pontine glioma | $938,955 | |
| Federal grant | Department of Health and Human Services · Phase II · Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme | $694,814 | |
| Federal grant | Department of Health and Human Services · Phase II · Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme | $694,814 | |
| Federal grant | Department of Health and Human Services · Phase II · Evaluation of the safety and efficacy of non-invasive sonodynamic therapy for diffuse intrinsic pontine glioma | $1,061,045 | |
| Private capital raised | Form D · SEC | $9,765,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme | $796,215 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1161 | BLOCKSYNOP INC | — | — |
| 1162 | Levita Magnetics International Corp. | — | $51M |
| 1163 | Spiral Therapeutics Inc | — | $37M |
| 1164 | SONALASENSE, INC. | — | $35M |
| 1165 | LATDE DIAGNOSTICS CORP. | — | — |
| 1166 | AUTHENTAG LLC | — | — |
| 1167 | Logiq.ai Inc. | — | $1.5M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Mark de SouzaDirector · Executive Officer
- MARK DE SOUZADirector · Executive Officer
- Stuart MarcusDirector · Executive Officer
- STUART MARCUSDirector · Executive Officer
- VINCENT SAIDirector
Patents
- Metabolic Targeting Of Low Grade Tumorsapplication
- Metabolic Targeting Of Low Grade Tumorsapplication
- Metabolic Targeting Of Low Grade Tumorsapplication
- Sonosensitizationapplication
- Sonosensitizationapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.